Dual Peptide-Dendrimer Conjugate Inhibits Acetylation of Transforming Growth Factor β-induced Protein and Improves Survival in Sepsis
- Dual Peptide-Dendrimer Conjugate Inhibits Acetylation of Transforming Growth Factor β-induced Protein and Improves Survival in Sepsis
- 김인산; Wonhwa Lee; Eun Ji Park; Oh Kwang Kwon; Hyelim Kim; Youngbum Yoo; Shin-Woo Kim; Young-Kyo Seo; Dong Hee Na; Jong-Sup Bae
- Issue Date
- VOL 246, 120000
- Sepsis is a potentially fatal complication of infections and there are currently no effective therapeutic options for severe sepsis. In this study, we revealed the secretion mechanism of transforming growth factor β-induced protein (TGFBIp) that was recently identified as a therapeutic target for sepsis, and designed TGFBIp acetylation inhibitory peptide (TAIP) that suppresses acetylation of lysine 676 in TGFBIp. To improve bioavailability and biodegradation of the peptide, TAIP was conjugated to polyamidoamine (PAMAM) dendrimers. Additionally, the cell-penetrating peptide (CPP) was conjugated to the TAIP-modified PAMAM dendrimers for the intracellular delivery of TGFBIp. The resulting nanostructures, decorated with TAIP and CPP via poly(ethylene glycol) linkage, improved the mortality and organ damage in the septic mouse model and suppressed lipopolysaccharide-activated severe vascular inflammatory responses in endothelial cells. Thus, the dendrimer-based nanostructures for delivery of TAIP using CPP show great promise in practical applications in sepsis therapy.
- Appears in Collections:
- KIST Publication > Article
- Files in This Item:
There are no files associated with this item.
- RIS (EndNote)
- XLS (Excel)
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.